You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
This article has a correction. Please see:
Abstract
Reevaluation of clinical data from the recent failed immunotherapy trials suggests that researchers should continue the quest to cure type 1 diabetes with immune therapies.
Footnotes
Citation: K. C. Herold, J. A. Bluestone, Type 1 Diabetes Immunotherapy: Is the Glass Half Empty or Half Full? Sci. Transl. Med. 3, 95fs1 (2011).
- Copyright © 2011, American Association for the Advancement of Science
